MC

Milenko Cicmil

Co-Founder and CEO of Tasca Therapeutics and Venture Partner at Cure Ventures

Boston, Massachusetts

Investor
VC

Invests in

Stages:

Series A
Seed

  • Min Investment:

    $100,000.00

  • Max Investment:

    $5,000,000.00

  • Target Investment:

    $1,500,000.00

Skills

Biochemistry
Biomarker Discovery
Biomarkers
Biotechnology
CRO
Cell Culture
Clinical Development
DMPK
Drug Design
Drug Development
Drug Discovery
In Vitro
In Vivo
Lead Change
Lifesciences
Pharmaceutical Industry
Pharmacology
Target Identification

Education

Work Experience

University of Reading

2020

  • Visiting Research Fellow at Univ. of Reading, UK

    2020

Cure Ventures

2021

  • Partner

    2021

AMP Discovery

2021 - 2022

  • Chairman Of The Board AMP Discovery

    2021 - 2022

Ipsen

2019 - 2021

  • Vice President Global Head of external Innovation

    2019 - 2021

FogPharma

2017 - 2019

  • Vice President - Translational Biology

    2017 - 2019

Merck

2013 - 2017

  • Director at Merck Innovation Hub

    2016 - 2017

  • Director Pharmacology Immuno-Oncology and Immunomodulation

    2013 - 2016

Merck

2011 - 2013

  • Director In vivo Pharmacology R&I

    2011 - 2013

AstraZeneca

2004 - 2011

  • Group Leader Integrative Pharmacology Discovery Bioscience - Inflammation

    2007 - 2011

  • Senior Research Scientist

    2004 - 2007

GE Healthcare

2002 - 2004

  • Senior Research Scientist

    2002 - 2004

Cancer Research UK

2000 - 2002

  • Translational Science - Research Fellow

    2000 - 2002